Search
Now showing items 1-5 of 5
An investigation into the bioavailability of a peroral cannabinoid-Pheroid® formulation
(Elsevier, 2019)
Cannabidiol (CBD), a phytocannabinoid isolated from the Cannabis sativa plant, has been investigated for its medicinal properties
including anti-psychotic, anti- emetic, anti-inflammatory, anxiolytic
and anti- convulsant ...
Therapeutic use and pharmacological safety of herbal medicines
(Elsevier, 2019)
In general, N80% of the world's population relies on traditional
medicine for their primary healthcare [1]. The use of complementary
herbal medicine provides an alternative option to modern allopathic
treatment for ...
The cardiovascular safety of Pheroid® in the conscious rat
(Elsevier, 2019)
The Pheroid® technology is a patented colloidal drug delivery
system comprised of a dispersed oil phase of omega 3 and omega 6
fatty acids emulsified in N2O saturated water. Pheroid® has
pharmaceutical applicability for ...
In vitro determination of the preclinical safety of Pheroid® doxorubicin formulations using patch clamp assays
(Elsevier, 2019)
One of the most active, widely used and well-known drugs in
breast cancer chemotherapy, doxorubicin (DOX), is an anthracycline
ring antibiotic derived from the bacteria Streptomyces peucetius. Its
clinical use is however, ...
The selective targeting of cancer cells by using Pheroid® as a drug delivery system
(Elsevier, 2019)
Pheroid® is a drug delivery system with possible use in the
treatment of chronic diseases such as cancer and that enhances the
efficacy of the treatment of chronic diseases [1]. Current cancer
treatment is non-selective, ...